Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

Loken, Michael R; Alonzo, Todd A; Pardo, Laura; Gerbing, Robert B; Raimondi, Susana C; Hirsch, Betsy A; Ho, Phoenix A; Franklin, Janet; Cooper, Todd M; Gamis, Alan S; Meshinchi, Soheil.
Blood; 120(8): 1581-8, 2012 Aug 23.
Artigo em Inglês | MEDLINE | ID: mdl-22649108